MedTrace Logo

Effects of Vaporized Marijuana on Neuropathic Pain

NCT01037088 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2018-01-31

Study results available
· View outcomes & findings →

Summary

This study theorized that a low dose of vaporized cannabis could alleviate nerve injury pain.

Conditions

Interventions

DRUG

Mild dose cannabis

3.53% THC by weight

DRUG

Low dose cannabis

1.29% THC by weight

DRUG

Cannabis

0.00% THC by weight

Sponsors & Collaborators

  • Center for Medicinal Cannabis Research

    collaborator OTHER

  • VA Northern California Health Care System

    collaborator FED

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Barth L Wilsey, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01037088 on ClinicalTrials.gov